XML 75 R62.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Details Narrative) - USD ($)
12 Months Ended
Feb. 16, 2022
Feb. 15, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2017
Subsequent Event [Line Items]          
Operating loss carryforward     $ 21,091,000   $ 9,895,000
Net operating loss carry forward expected to expire amount     $ 11,196,000    
Net operating loss expiration term       2034 through 2037  
NOLs usage against taxable income, percentage     80.00% 80.00%  
Percentage of ownership change     50.00%    
NOLs carryforwards term     three-year period    
Subsequent Event [Member]          
Subsequent Event [Line Items]          
Proceeds from Issuance of Common Stock   $ 22,000,000      
Number of warrants issued   6,572,808      
Number of warrants issued   290,557      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period   761,670      
[custom:PercentageOfOverallotment]   15.00%      
Subsequent Event [Member] | Common Stock [Member]          
Subsequent Event [Line Items]          
Number of warrants issued   5,811,138      
Subsequent Event [Member] | Warrant [Member]          
Subsequent Event [Line Items]          
Number of warrants issued   5,811,138      
Vesting period, term 5 years        
Subsequent Event [Member] | Warrant [Member] | Private Placement [Member]          
Subsequent Event [Line Items]          
Number of warrants issued   1,052,227      
Number of warrants issued   290,557      
Vesting period, term   5 years      
Exercise price per share   $ 5.1625      
Subsequent Event [Member] | Warrant [Member] | Over-Allotment Option [Member]          
Subsequent Event [Line Items]          
Number of warrants issued   761,670      
Vesting period, term   5 years      
Exercise price per share   $ 5.00